Načítá se...
The Use of Biomarkers in Prostate Cancer Screening and Treatment
Prostate cancer screening and diagnosis has been guided by prostate-specific antigen levels for the past 25 years, but with the most recent US Preventive Services Task Force screening recommendations, as well as concerns regarding overdiagnosis and overtreatment, a new wave of prostate cancer biomar...
Uloženo v:
| Vydáno v: | Rev Urol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MedReviews, LLC
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5811879/ https://ncbi.nlm.nih.gov/pubmed/29472826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3909/riu0772 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|